NCT04176731View on ClinicalTrials.gov

Prepivotal Omnipod Horizon™ Automated Glucose Control System

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Omnipod Horizon™ Automated Glucose Control System

The Omnipod Horizon™ Automated Glucose Control System will provide automated insulin delivery

Trial Locations (6)

10029

Mount Sinai, New York

22904

University of Virginia, Charlottesville

30318

Atlanta Diabetes, Atlanta

55416

International Diabetes Center, Saint Louis Park

80045

University of Colorado Denver, Denver

94305

Stanford University, Palo Alto

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY